Advertisement

Latest Articles in pharma

Collaboration Can Lead Us To Better Discovery

Drug discovery has changed. The model of big pharma retaining all the knowledge within has become obsolete

Read More

Sun Pharma Buys Novartis’ Anti-cancer Brand Odomzo For $175 Million

Reason for selling this new anti-cancer drug by Novartis, which consolidated its global oncology business by acquiring the entire cancer drug portfolio of GlaxoSmithKline (GSK) in a $16 billion global deal in March 2015, is not disclosed

Read More

Lupin, Eli Lilly Expand Partnership In India

Lupin will market and sell Eglucent through its own specialty field force while Lilly will be responsible for manufacturing and import

Read More

‘Qualiminds Hopes To Improve The Indian Drug Industry’s Image’

K. Anand, CEO and managing director, Qualiminds, tells BW Businessworld that the pharmaceutical industry’s attitude to compliance with regulatory norms has to change

Read More

Dr Reddy's Profit Misses View As Emerging Markets Sales Fall

Dr Reddy's Laboratories Ltd, India's second-largest drugmaker, reported a quarterly profit that was below analysts' estimates due to a drop in sales, mainly in emerging markets

Read More

Sun Pharma Completes Rs 675-crore Share Buyback

As per Sebi guidelines, 15 per cent of the buyback offer is reserved for shareholders holding shares having a market value of not more than Rs 2,00,000 as on the record date

Read More

Drug Firms Facing Challenging Times Due To Price Control: Cipla

Drug companies are facing a tough environment due to the government bringing more products under the price control policy as also tightening of registration procedure that has impacted time to market newer products

Read More

Zydus Cadila Ties Up With Takeda To Develop Chikungunya Vaccine

Cadila Healthcare says the terms of the agreement are not disclosed, but it is expected that this partnership will boost access to medicines in the future

Read More

Will Desi Slogan Put Patients At Risk?

With India’s regulatory mechanism as weak as it is, the latest government advisory could end up being the pass to small-time players to push their subpar products into government hospitals under a competitive price tag

Read More

Piramal Acquires US Drug Maker Ash Stevens For Rs 354 Crore

Ajay Piramal-led pharma-to-finance group Piramal Enterprises has signed a definitive agreement to acquire 100%stake of the US-based drug developer and custom manufacturer Ash Stevens Inc for a total consideration of Rs 353.4 crore

Read More

Indian Pharma Market Regains Growth

Indian pharmaceutical market regained its growth momentum in July after a weak trajectory in the previous three to four months

Read More

IVF: Fertile Ground

Ever larger number of Indians are suffering from infertility, and domestic and foreign players are rushing in to tap the IVF treatment market

Read More

GSK Pharma Q1 Net Down 23% At Rs 72.27 Crore

GlaxoSmithKline Pharmaceuticals on Thursday reported a 23.12 per cent fall in standalone net profit at Rs 72.27 crore for the June quarter, on account of increase in expenditure

Read More